![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 11
2022
Kraus, Fabian B. T.; Topalov, Nicole E.; Deuster, E.; Hysenaj, I.; Mayr, D.; Chelariu-Raicu, A.; Beyer, S.; Kolben, T.; Burges, A.; Mahner, S.; Trillsch, F.; Jeschke, U. und Czogalla, B.
(2022):
Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 6: S. 2501-2511
[PDF, 1MB]
Bossart, M.; Plett, H.; Kraemer, B.; Braicu, E.; Czogalla, B.; Klar, M.; Singer, S.; Mayr, D.; Staebler, A.; du Bois, A.; Kommoss, S.; Link, T.; Burges, A.; Heitz, F.; Grube, M.; Trillsch, F.; Harter, P.; Wimberger, P.; Buderath, P. und Hasenburg, A.
(2022):
Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database.
In: Archives of Gynecology and Obstetrics, Bd. 307, Nr. 4: S. 1155-1162
2019
Ray-Coquard, I.; Pautier, P.; Pignata, S.; Perol, D.; Gonzalez-Martin, A.; Berger, R.; Fujiwara, K.; Vergote, I.; Colombo, N.; Maenpaa, J.; Selle, F.; Sehouli, J.; Lorusso, D.; Alia, E. M. Guerra; Reinthaller, A.; Nagao, S.; Lefeuvre-Plesse, C.; Canzler, U.; Scambia, G.; Lortholary, A.; Marme, F.; Combe, P.; de Gregorio, N.; Rodrigues, M.; Buderath, P.; Dubot, C.; Burges, A.; You, B.; Pujade-Lauraine, E. und Harter, P.
(2019):
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
In: New England Journal of Medicine, Bd. 381, Nr. 25: S. 2416-2428
2017
Rottmann, Miriam; Burges, A.; Mahner, S.; Anthuber, C.; Beck, T.; Grabs, D.; Schnelzer, A.; Kiechle, M.; Mayr, D.; Pölcher, M.; Schubert-Fritschle, G. und Engel, J.
(2017):
Cancer of the ovary, fallopian tube, and peritoneum. A population-based comparison of the prognostic factors and outcomes.
In: Journal of cancer research and clinical oncology
2016
Rottmann, Miriam; Beck, T.; Burges, A.; Dannecker, C.; Kiechle, M.; Mayr, D.; Schlesinger-Raab, Anne; Schubert-Fritschle, Gabriele und Engel, Jutta
(2016):
Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16-year period (1998-2013): a population-based analysis.
In: Journal of Cancer Research and Clinical Oncology, Bd. 142, Nr. 6: S. 1331-1341
Marme, F.; Harter, P.; Hauke, J.; Heitz, F.; Reuss, A.; Kommoss, S.; Heimbach, A.; Prieske, K.; Richters, L.; Burges, A.; Neidhardt, G.; Gregorio, N. de; El-Balat, A.; Hilpert, F.; Meier, W.; Heubner, M.; Kast, K.; Braicu, I.; Hahnen, E. und Schmutzler, R.
(2016):
Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1).
In: International Journal of Gynecological Cancer, Bd. 26: S. 194-195
Mahner, S.; Trillsch, F.; Chi, D.; Harter, P.; Pfisterer, J.; Hilpert, F.; Burges, A.; Weissenbacher, T. und Du Bois, A.
(2016):
Neoadjuvant chemotherapy in ovarian cancer revisited.
In: Annals of Oncology, Bd. 27: S. 30-32
Lindemann, K.; Kristensen, G.; Mirza, M. R.; Davies, L.; Hilpert, F.; Romero, I.; Ayhan, A.; Burges, A.; Rubio, M. J.; Raspagliesi, F.; Huizing, M.; Creemers, G.-J.; Lykka, M.; Lee, C. K.; Gebski, V. und Pujade-Lauraine, E.
(2016):
Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial.
In: Annals of Oncology, Bd. 27, Nr. 8: S. 1505-1510
2009
Hölscher, G.; Anthuber, C.; Bastert, G.; Burges, A.; Mayr, D.; Oberlechner, E.; Schubert-Fritschle, Gabriele; Sinz, S.; Sommer, H.; Schmalfeldt, B. und Engel, Jutta
(2009):
Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up.
In: Acta Obstetricia et Gynecologica Scandinavica, Bd. 88, Nr. 4: S. 440-448
2006
Mayr, D.; Kanitz, V.; Amann, G.; Engel, Jutta; Burges, A.; Löhrs, U. und Diebold, J.
(2006):
HER-2/neu gene amplification in ovarian tumours: a comprehensive immunohistochemical and FISH analysis on tissue microarrays.
In: Histopathology, Bd. 48, Nr. 2: S. 149-156
2000
Meier, W.; Gropp, M.; Burges, A. und Hepp, H.
(2000):
Therapie bei Progression und Rezidiv des Ovarialkarzinoms.
In: Onkologie, Nr. 2: S. 35-39
[PDF, 112kB]